The MonoPrep Pap Test for the detection of cervical cancer and its precursors: Part I: Results of a Multicenter Clinical Trial
Abstract The MonoPrep Pap Test (MPPT; MonoGen, Lincolnshire, IL) is a novel, liquid-
based specimen collection and processing technology for cytologic and molecular testing …
based specimen collection and processing technology for cytologic and molecular testing …
ThinPrep® Pap Test™: Performance and biopsy follow‐up in a university hospital
AB Carpenter, DD Davey - … International Journal of the …, 1999 - Wiley Online Library
Abstract BACKGROUND The ThinPrep® Pap Test™(TP), a liquid‐based cervical cytology
preparation, was approved for use in the US in 1996. The purpose of this study was to …
preparation, was approved for use in the US in 1996. The purpose of this study was to …
Use of the Thin Prep® Pap Test™ in clinical practice
BJ Guidos, SM Selvaggi - Diagnostic cytopathology, 1999 - Wiley Online Library
Abstract The Thin Prep® Pap Test™(Cytyc Corp., Boxborough, MA) received approval by
the Food and Drug Administration in May 1996 as an alternative to the traditional …
the Food and Drug Administration in May 1996 as an alternative to the traditional …
Efficacy of a liquid‐based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer
J Weintraub, A Morabia - Diagnostic cytopathology, 2000 - Wiley Online Library
The performance of the ThinPrep® Pap Test™(TP)(Cytyc Corp., Boxborough, MA) for
detection of cervical cancer precursors in a population with a low incidence of disease was …
detection of cervical cancer precursors in a population with a low incidence of disease was …
Does liquid-based technology really improve detection of cervical neoplasia?
JH Obwegeser, S Brack - Acta cytologica, 2001 - karger.com
OBJECTIVE: To compare the sensitivity, specificity and specimen adequacy of the ThinPrep
Pap Test (TP) with the conventional Pap Test (CV) in a low-risk population with subsequent …
Pap Test (TP) with the conventional Pap Test (CV) in a low-risk population with subsequent …
The ThinPrep Pap test. A review of clinical studies.
J Linder, D Zahniser - Acta cytologica, 1997 - europepmc.org
Study design Clinical trials of the ThinPrep Beta and the ThinPrep 2000 performed in the
United States were reviewed. In each a single sample was used to first prepare a …
United States were reviewed. In each a single sample was used to first prepare a …
Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison
MS Chacho, ME Mattie… - … International Journal of …, 2003 - Wiley Online Library
Abstract BACKGROUND The ThinPrep® Papanicolaou (Pap) test, a liquid‐based alternative
to the long‐used conventional Pap smear, received Food and Drug Administration approval …
to the long‐used conventional Pap smear, received Food and Drug Administration approval …
Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing.
ME Sherman, M Mendoza, KR Lee… - Modern pathology: an …, 1998 - europepmc.org
The performance of thin-layer cervical cytology with the use of ThinPrep (Cytyc Corporation,
Boxborough, MA) was assessed by comparing the original independent diagnosis of …
Boxborough, MA) was assessed by comparing the original independent diagnosis of …
Liquid‐based cytology and conventional cervical smears: a comparison study in an Asian screening population
ANY Cheung, EF Szeto, BSY Leung… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND This study compared the findings of cervical cytology screening by
ThinPrep Papanicoloau (Pap) tests (TP) with the findings of screening by conventional …
ThinPrep Papanicoloau (Pap) tests (TP) with the findings of screening by conventional …
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing
ME Sherman, MH Schiffman, AT Lorincz… - … Journal of the …, 1997 - Wiley Online Library
BACKGROUND Several new techniques have been developed to improve the sensitivity of
cervical carcinoma screening and reduce equivocal cytologic diagnoses referred to as …
cervical carcinoma screening and reduce equivocal cytologic diagnoses referred to as …